As of 2026-01-04, the Relative Valuation of Cytokinetics Inc (CYTK) is (149.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 61.73 USD, the upside of Cytokinetics Inc based on Relative Valuation is -341.9%.
The range of the Relative Valuation is (111.32) - (154.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 25.2x | 21.5x |
| Forward P/E multiples | 18.1x - 36.0x | 27.0x |
| Fair Price | (111.32) - (154.99) | (149.30) |
| Upside | -280.3% - -351.1% | -341.9% |
| Date | P/E |
| 2026-01-02 | -10.04 |
| 2025-12-31 | -10.33 |
| 2025-12-30 | -9.98 |
| 2025-12-29 | -10.04 |
| 2025-12-26 | -10.26 |
| 2025-12-24 | -10.44 |
| 2025-12-23 | -10.29 |
| 2025-12-22 | -10.67 |
| 2025-12-19 | -10.20 |
| 2025-12-18 | -10.11 |
| 2025-12-17 | -9.73 |
| 2025-12-16 | -10.08 |
| 2025-12-15 | -10.11 |
| 2025-12-12 | -10.30 |
| 2025-12-11 | -9.88 |
| 2025-12-10 | -9.81 |
| 2025-12-09 | -10.02 |
| 2025-12-08 | -10.43 |
| 2025-12-05 | -10.68 |
| 2025-12-04 | -10.82 |
| 2025-12-03 | -10.51 |
| 2025-12-02 | -10.33 |
| 2025-12-01 | -10.74 |
| 2025-11-28 | -11.08 |
| 2025-11-26 | -11.08 |
| 2025-11-25 | -10.98 |
| 2025-11-24 | -10.93 |
| 2025-11-21 | -10.64 |
| 2025-11-20 | -10.32 |
| 2025-11-19 | -10.53 |
| 2025-11-18 | -10.76 |
| 2025-11-17 | -10.89 |
| 2025-11-14 | -10.80 |
| 2025-11-13 | -10.65 |
| 2025-11-12 | -10.72 |
| 2025-11-11 | -10.81 |
| 2025-11-10 | -10.11 |
| 2025-11-07 | -9.78 |
| 2025-11-06 | -9.80 |
| 2025-11-05 | -9.62 |
| 2025-11-04 | -9.69 |
| 2025-11-03 | -9.76 |
| 2025-10-31 | -10.34 |
| 2025-10-30 | -10.12 |
| 2025-10-29 | -10.08 |
| 2025-10-28 | -10.08 |
| 2025-10-27 | -9.79 |
| 2025-10-24 | -9.40 |
| 2025-10-23 | -9.35 |
| 2025-10-22 | -8.90 |